| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type |
| A1 | 1 | 45 | F | Uterus | Endometrium tissue | * | * | * | Normal |
| A2 | 2 | 18 | F | Uterus | Endometrium tissue | * | * | * | Normal |
| A3 | 3 | 41 | F | Cervix | Adjacent normal endometrium tissue | * | * | * | NAT |
| A4 | 4 | 36 | F | Cervix | Cancer adjacent cervical canals tissue | * | * | * | AT |
| A5 | 5 | 72 | F | Cervix | Adjacent normal cervix tissue | * | * | * | NAT |
| A6 | 6 | 65 | F | Cervix | Adjacent normal cervix tissue | * | * | * | NAT |
| A7 | 7 | 40 | M | Skeletal muscle | Skeletal muscle tissue | * | * | * | Normal |
| A8 | 8 | 49 | F | Skeletal muscle | Adjacent normal skeletal muscle tissue | * | * | * | NAT |
| A9 | 9 | 50 | M | Skeletal muscle | Skeletal muscle tissue | * | * | * | Normal |
| B1 | 10 | 45 | M | Skin | Skin tissue | * | * | * | Normal |
| B2 | 11 | 37 | M | Skin | Skin tissue | * | * | * | Normal |
| B3 | 12 | 18 | F | Skin | Skin tissue | * | * | * | Normal |
| B4 | 13 | 35 | M | Nerve | Peripheral nerve tissue | * | * | * | Normal |
| B5 | 14 | 25 | M | Nerve | Peripheral nerve tissue | * | * | * | Normal |
| B6 | 15 | 40 | M | Nerve | Peripheral nerve tissue | * | * | * | Normal |
| B7 | 16 | 21 | F | Lung | Lung and pleura tissue | * | * | * | Normal |
| B8 | 17 | 26 | F | Cardiac pericardium | Mesothelium tissue | * | * | * | Normal |
| B9 | 18 | 19 | M | Cardiac pericardium | Pericardium and mesothelium tissue | * | * | * | Normal |
| C1 | 19 | 43 | M | Cerebrum | Glioblastoma | 4 | * | * | Malignant |
| C2 | 20 | 65 | F | Cerebrum | Atypical meningioma | * | * | * | Malignant |
| C3 | 21 | 61 | F | Cerebrum | Glioblastoma | 4 | * | * | Malignant |
| C4 | 22 | 39 | F | Cerebrum | Oligodendroglioma of right parietal lobe | * | * | * | Malignant |
| C5 | 23 | 63 | F | Ovary | High grade serous carcinoma | * | T2N0M0 | II | Malignant |
| C6 | 24 | 29 | F | Ovary | High grade serous carcinoma | * | T3N0M0 | III | Malignant |
| C7 | 25 | 16 | F | Pancreas | Islet cell tumor | * | * | * | Malignant |
| C8 | 26 | 64 | M | Pancreas | Duct adenocarcinoma | 2 | T3N0M0 | IIA | Malignant |
| C9 | 27 | 32 | M | Testis | Seminoma | * | T1N0M0 | I | Malignant |
| D1 | 28 | 30 | M | Testis | Embryonal carcinoma | * | T2N0M0 | IB | Malignant |
| D2 | 29 | 33 | F | Thyroid | Medullary carcinoma | * | T3N0M0 | I | Malignant |
| D3 | 30 | 46 | F | Thyroid | Papillary carcinoma | * | T4N0M0 | IV | Malignant |
| D4 | 31 | 67 | F | Breast | Intraductal carcinoma with early infiltrate | * | TisN0M0 | 0 | Malignant |
| D5 | 32 | 48 | F | Breast | Invasive ductal carcinoma | 2 | T3N1M0 | IIIA | Malignant |
| D6 | 33 | 58 | F | Breast | Invasive ductal carcinoma | 2 | T2N1M0 | IIB | Malignant |
| D7 | 34 | 21 | M | Spleen | Diffuse B-cell lymphoma | * | * | * | Malignant |
| D8 | 35 | 61 | M | Lung | Small cell undifferentiated carcinoma | * | T2N0M0 | IB | Malignant |
| D9 | 36 | 66 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
| E1 | 37 | 42 | M | Lung | Adenocarcinoma | 3 | T1N0M0 | IA | Malignant |
| E2 | 38 | 68 | M | Esophagus | Squamous cell carcinoma | 2 | T3N1M0 | IIIA | Malignant |
| E3 | 39 | 63 | M | Esophagus | Adenocarcinoma | 3 | T3N0M0 | IIA | Malignant |
| E4 | 40 | 73 | F | Stomach | Mucinous adenocarcinoma | 3 | T2N1M0 | IIA | Malignant |
| E5 | 41 | 64 | F | Small intestine | Adenocarcinoma with necrosis (sparse) | 3 | T4N0M0 | IIB | Malignant |
| E6 | 42 | 71 | F | Small intestine | Malignant interstitialoma | * | T2N0M0 | I | Malignant |
| E7 | 43 | 72 | F | Colon | Adenocarcinoma | 1 | T4N0M0 | IIB | Malignant |
| E8 | 44 | 54 | M | Colon | Interstitialoma | * | T2N0M0 | I | Malignant |
| E9 | 45 | 36 | M | Rectum | Adenocarcinoma | 2 | T2N0M0 | I | Malignant |
| F1 | 46 | 63 | F | Rectum | Malignant interstitialoma | * | T2N0M0 | I | Malignant |
| F2 | 47 | 55 | F | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | III | Malignant |
| F3 | 48 | 17 | F | Liver | Hepatoblastoma | * | * | * | Malignant |
| F4 | 49 | 60 | M | Kidney | Clear cell carcinoma | 1 | T2N0M0 | II | Malignant |
| F5 | 50 | 80 | M | Prostate | Adenocarcinoma (Gleason grade:4, gleason score:4+4) | * | T2N1M1C | IV | Malignant |
| F6 | 51 | 77 | M | Prostate | Adenocarcinoma (Gleason grade:5, gleason score:5+4) | * | T2N0M0 | IIA | Malignant |
| F7 | 52 | 56 | F | Uterus | Lowly malignant leiomyosarcoma | * | T2BN0M0 | IIB | Malignant |
| F8 | 53 | 50 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1BN0M0 | IB | Malignant |
| F9 | 54 | 57 | F | Uterus | Clear cell carcinoma | * | T1CN0M0 | IC | Malignant |
| G1 | 55 | 36 | F | Cervix | Squamous cell carcinoma | 3 | T1BN0M0 | IB | Malignant |
| G2 | 56 | 49 | F | Cervix | Invasive squamous cell carcinoma | 3 | T2N0M0 | II | Malignant |
| G3 | 57 | 20 | F | Skeletal muscle | Embryonal rhabdomyosarcom of left leg | * | T1AN0M0 | IA | Malignant |
| G4 | 58 | 70 | F | Rectum | Malignant melanoma | * | T4N0M0 | IIB | Malignant |
| G5 | 59 | 61 | M | Skin | Basal cell carcinoma of left face | * | T2N0M0 | IIA | Malignant |
| G6 | 60 | 64 | M | Skin | Squamous cell carcinoma with necrosis of chest wall | 2 | T3N0M0 | IIA | Malignant |
| G7 | 61 | 21 | M | Nerve | Neurofibroma of back | * | * | * | Malignant |
| G8 | 62 | 1 | F | Retroperitoneum | Neuroblastoma | * | * | * | Malignant |
| G9 | 63 | 60 | M | Peritoneum | Malignant mesothelioma | * | T2N0M0 | II | Malignant |
| H1 | 64 | 55 | M | Lymph node | Diffuse B cell lymphoma of armpit | * | * | * | Malignant |
| H2 | 65 | 50 | F | Lymph node | Diffuse B cell lymphoma of right thigh | * | * | * | Malignant |
| H3 | 66 | 27 | M | Lymph node | Hodgkin's lymphoma of left groin (mixed cell type) | * | * | * | Malignant |
| H4 | 67 | 36 | M | Lymph node | Anaplastic large cell lymphoma of left groin | * | * | * | Malignant |
| H5 | 68 | 58 | F | Bladder | High grade urothelial carcinoma | * | T2N0M0 | II | Malignant |
| H6 | 69 | 62 | M | Bladder | Lowly malignant leiomyosarcoma | * | T2N0M0 | II | Malignant |
| H7 | 70 | 51 | M | Cartilage | Well differentiated osteosarcoma of left femur | * | T2N0M0 | II | Malignant |
| H8 | 71 | 48 | F | Peritoneum | Highly malignant pleomorphic rhabdomyosarcoma | * | T2N0M0 | II | Malignant |
| H9 | 72 | 60 | F | Smooth muscle | Moderate malignant leiomyosarcoma of left buttock | * | T2BN0M0 | IIB | Malignant |
| Tissue Marker |
